|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.805 USD | +2.28% |
|
-0.26% | -7.33% |
| Market Cap | 1.97B 1.73B 1.59B 1.47B 2.8B 188B 2.84B 19.07B 7.48B 92.55B 7.41B 7.25B 321B | P/E 2026 * |
-4.28x | P/E 2027 * | -3.98x |
|---|---|---|---|---|---|
| Enterprise Value | 1.53B 1.34B 1.24B 1.14B 2.17B 146B 2.21B 14.79B 5.8B 71.77B 5.75B 5.62B 249B | EV / Sales 2026 * |
23.5x | EV / Sales 2027 * | 19.7x |
| Free-Float |
96.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Recursion Pharmaceuticals, Inc.
| 1 day | +2.28% | ||
| 1 week | -0.26% | ||
| Current month | +3.27% | ||
| 1 month | +17.70% | ||
| 3 months | +14.50% | ||
| 6 months | -18.67% | ||
| Current year | -7.33% |
| 1 week | 3.63 |  | 4.09 |
| 1 month | 2.95 | | 4.09 |
| Current year | 2.77 | | 5.24 |
| 1 year | 2.77 | | 7.18 |
| 3 years | 2.77 | | 16.74 |
| 5 years | 2.77 | | 42.81 |
| 10 years | 2.77 | | 42.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Najat Khan
CEO | Chief Executive Officer | 43 | 2025-12-31 |
Ben Taylor
DFI | Director of Finance/CFO | 48 | 2024-11-19 |
Vicki Goodman
CTO | Chief Tech/Sci/R&D Officer | 57 | 2026-04-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Blake Borgeson
BRD | Director/Board Member | 44 | 2013-11-03 |
Dean Li
BRD | Director/Board Member | 62 | 2013-11-03 |
Zavain Dar
BRD | Director/Board Member | 37 | 2016-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-30 | Free | Founder | 3,747 | 0.0007% | ||
| 06-30 | Free | Director | 5,109 | 0.0010% | ||
| 06-17 | Sell | Director | -3,963 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.28% | -0.26% | -32.20% | -47.43% | 1.97B | |
| -0.38% | -3.44% | +71.35% | +126.62% | 56.71B | |
| +4.91% | -3.30% | +71.97% | +92.14% | 51.3B | |
| +1.46% | +6.01% | +22.64% | +479.95% | 25.26B | |
| -0.73% | -4.57% | -16.72% | -13.35% | 23.65B | |
| +3.93% | +7.11% | +44.20% | -1.96% | 18.69B | |
| +2.01% | +2.99% | +40.72% | -24.46% | 17.71B | |
| -6.84% | +4.81% | +201.88% | +348.11% | 17.7B | |
| -0.92% | +8.90% | +38.48% | - | 14.26B | |
| +1.21% | +1.58% | +28.73% | +197.48% | 14.1B | |
| Average | +0.70% | +3.24% | +47.11% | +128.57% | 24.14B | |
| Weighted average by Cap. | +1.02% | +2.15% | +57.70% | +141.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 65.27M 57.09M 52.65M 48.72M 92.46M 6.23B 94.01M 631M 247M 3.06B 245M 240M 10.6B | 85.54M 74.83M 69M 63.85M 121M 8.16B 123M 826M 324M 4.01B 321M 314M 13.89B |
| Net income | -457M -400M -368M -341M -647M -43.59B -658M -4.41B -1.73B -21.41B -1.71B -1.68B -74.15B | -510M -446M -412M -381M -723M -48.71B -735M -4.93B -1.93B -23.92B -1.92B -1.87B -82.85B |
| Net Debt | -443M -388M -358M -331M -628M -42.31B -639M -4.28B -1.68B -20.78B -1.66B -1.63B -71.97B | -285M -250M -230M -213M -404M -27.23B -411M -2.76B -1.08B -13.37B -1.07B -1.05B -46.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | US$3.780 | +1.62% | 11,572,562 |
| 26-07-08 | US$3.720 | -3.12% | 22,705,628 |
| 26-07-07 | US$3.840 | -3.03% | 28,855,557 |
| 26-07-06 | US$3.960 | +4.21% | 38,065,212 |
| 26-07-02 | US$3.800 | +3.54% | 32,680,470 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RXRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
